I have traded this a number of times. Back in at 5.90 this morning. Below is a statement from the Motley Fool analyst I heard about this stock from. Unfortunate I lost track of his coverage and all my trades were done after this was released, and before I read this, except when I got back in today.

Extendicare (NASDAQOTH:EXETF) -- This was a truly unfortunate experience, as management just worked over
shareholders in a terrible way. It ran the REIT's American business into the ground and then sold it at a low point
(very much like buy high/sell low investors). The conference call announcing the deal was unbelievable, and you
could hear the anxiety in the CEO's voice as he delivered the news and parried questions from analysts. With only
a little cash going back to shareholders in the form of a stock buyback -- surely after some investors twisted
management's arm -- shareholders were right to dump the stock. It would be much more accretive to buy back stock
at these prices, but management wants to expand the business. That would be poor capital allocation.
James Royal
(TMFRoyal)
Jan 23, 2015 at 10:06AM

Extendicare breaking resistance level. This should get good from here . LONG+

I want to talk $EXETF $TROV.. Health-care, Biopharm, and retail...

Extendicare (TSE:EXE) had its price target upped by CIBC from C$7.50 to C$8.00 in a research note issued to investors on Friday. The firm currently has a sector perform rating on the stock.

http://www.mideasttime.com/extendicare-given-new-c8-00-price-target-at-cibc-exe/362393/

Extendicare announced 10% share buyback program:

http://finance.yahoo.com/news/extendicare-announces-intention-issue-normal-223000319.html